% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • qdelfan qdelfan Nov 18, 2012 11:39 AM Flag

    VRTX starts VX 135+ Ribavirin phase II combination trial

    Soon to follow is announcement of initiation of combination trials with VX 135 with GSK's and JNJ's drugs, and VX 135 with Vertex's other hep C assets (telaprevir and VX 222), and more importantly the initiation in early 2013 of Phase 3 809/770 trials, and initiation of clinical trials of VX 509 in other inflammatory diseases. Of course VX 661/770 trial results should be a major catalyst as well in the first half of 2013. The potential for VX 787 will hopefully be revealed around the next two investor conferences in the coming weeks.

    Sentiment: Strong Buy

82.92+1.09(+1.33%)Oct 20 4:00 PMEDT